CTX450 Trademark
CTX450 is a USPTO trademark filed by CRISPR Therapeutics AG. Status: Pending.
Trademark Facts
| Mark | CTX450 |
|---|---|
| Serial Number | 98589124 |
| Status | Pending |
| Filing Date | 2024-06-06 |
| Mark Type | Word |
| Nice Classes | 005 (Pharmaceuticals), 042 (Software & IT) |
| Owner | CRISPR Therapeutics AG |
| Attorney of Record | Tiffany D. Gehrke |
| Prosecution Events | 16 |
| Latest Event | EXRA on 2026-03-06 |
Goods & Services
Cells for medical or clinical use in the field of in vivo gene editing therapy for the treatment of liver, neurological, and neurovascular diseases or conditions; pharmaceutical and biopharmaceutical agents for the treatment of liver, neurological, and neurovascular diseases or conditions in the field of in vivo gene editing therapy; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of liver, neurological, and neurovascular diseases or conditions in the field of in vivo gene editing therapy; Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders in the field of in vivo gene editing therapy; gene editing, namely, pharmaceutical research and development in the field of in vivo gene editing therapy